Activation of AhR signaling in the tumor microenvironment may stimulate cancer cell proliferation, and migration by enhanced expression of proangiogenic mediators and factors increased cancer cell motility, including the vascular endothelial growth factor (VEGF) and TGF-β [48,176]. This evidence concerns the gene TGFB1 and cancer.